Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer Biomarkers.

Saved in:
Bibliographic Details
Title: Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer Biomarkers.
Authors: Al-Kateb H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: alkateb.hussam@mayo.edu., Knight SM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Sivasankaran G; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Voss JS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Pitel BA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Blommel JH; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Jerde CR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Rumilla KM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Lee JL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Mattson NR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Lauer KP; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Zimmerman Zuckerman EA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Hofich CD; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Milosevic D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Thompson J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Tillmans LS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Stai TT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Dasari S; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Pryzbylski AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Mullineaux LG; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Ida CM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Gupta S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Kipp BR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Halling KC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: halling.kevin@mayo.edu.
Source: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2025 Apr; Vol. 27 (4), pp. 292-305. Date of Electronic Publication: 2025 Jan 31.
Publication Type: Journal Article; Validation Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1943-7811
DOI:10.1016/j.jmoldx.2025.01.002